Close Menu

NEW YORK – The Office of Biomedical Advanced Research and Development Authority (BARDA) is now seeking applications from diagnostics makers to support the development of tests for novel coronavirus 2019-nCoV.

On Tuesday, under the auspices of its Division of Research, Innovation & Ventures (DRIVe), BARDA launched an Easy Broad Agency Announcement, or EZ-BAA, funding solicitation that is specifically for diagnostics, enabling diagnostics developers to submit assays for funding.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.